Notch Therapeutics
PrivateLast Round
M&A
Apr 2, 2025
Est. Valuation
$20M
Total Funding Raised
$90M
Company Overview
Notch Therapeutics operates in Healthcare & Life Sciences and is based in Vancouver. Its latest recorded funding round was a Series A round in February 2021.
Notch Therapeutics is a biotechnology company that develops renewable, induced pluripotent stem cell (iPSC)-derived immunotherapies for cancer and other diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Notch Therapeutics Comparables
Compare Notch Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Shinobi Therapeutics, Inc. | 84% | |
| Shoreline Biosciences | 82% | |
| Rebirthel Co., Ltd. | 82% |
For institutional investors. Book with your work email.
Notch Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| M&A | Apr 2, 2025 | ||||
| Series A | Feb 10, 2021 | ||||
| Seed | Nov 1, 2019 |
For institutional investors. Book with your work email.
Notch Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| EcoR1 Capital | Series A |
| Amplitude Ventures | Series A |
| CCRM | Series A, Seed |
| CCRM Enterprises Inc. | Series A |
| Lumira Ventures | Seed, Series A |
| Casdin Capital | Series A |
| TIAP | Seed |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 2, 2025
Roche Holding led the M&A round.
- Nov 1, 2019
$5M round with participation from Lumira Ventures and TIAP.
For institutional investors. Book with your work email.
Notch Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Notch Therapeutics's valuation, stock price, and market status.
Is Notch Therapeutics a public or private company?
Notch Therapeutics is a private company.
What is the current stock price of Notch Therapeutics?
Notch Therapeutics is a private company, so its shares have no public market price. Caplight tracks Notch Therapeutics's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Notch Therapeutics worth (valuation)?
Notch Therapeutics's valuation is estimated at $20.0M based on funding round data.
Can I buy Notch Therapeutics stock?
Notch Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Notch Therapeutics's last funding round?
Notch Therapeutics's most recent funding round was M&A on April 2, 2025.
Who are the main investors in Notch Therapeutics?
Key investors in Notch Therapeutics include EcoR1 Capital, Amplitude Ventures, CCRM, CCRM Enterprises Inc., Lumira Ventures.
Will Notch Therapeutics IPO soon?
No public IPO plans have been announced for Notch Therapeutics.
How can I track Notch Therapeutics secondary market activity?
Caplight tracks bids, offers, and trades in Notch Therapeutics's shares on secondary markets.